Raveen Parboosing

Citée par

	Toutes	Depuis 2020
Citations	3627	2560
indice h	25	18
indice i10	45	30

900

450

225

675

201020112012201320142015201620172018201920202021202220232024202514 26 43 74 99 111 123 151 157 180 219 304 890 675 423 38

Accès public

Tout afficher

21 articles

4 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Gert (HG) KrugerResearch Professor, Catalysis and Peptide Research Unit, UKZNAdresse e-mail validée de ukzn.ac.za
Thavendran GovenderAnsynth PTY LTDAdresse e-mail validée de ansynth.co.za
Pravi MoodleyClinical Virologist, National Health Laboratory Service and University of KwaZulu-NatalAdresse e-mail validée de ukzn.ac.za
Glenn MaguireUKZNAdresse e-mail validée de ukzn.ac.za
Kerusha GovenderUniversity of KwaZulu NatalAdresse e-mail validée de ukzn.ac.za
Linda A. BesterUniversity of KwaZulu-NatalAdresse e-mail validée de ukzn.ac.za
Patrick GovenderUniversity of Kwazulu-NatalAdresse e-mail validée de ukzn.ac.za
Nokukhanya MsomiUniversity of KwaZulu-NatalAdresse e-mail validée de msomi.co.za
Michelle GordonUniversity of KwaZulu NatalAdresse e-mail validée de ukzn.ac.za
Anou M. SomboroUniversity of KwuZulu NatalAdresse e-mail validée de ukzn.ac.za
Per I ArvidssonDirector, Science for Life Laboratory, Karolinska Institute, Sweden & Research Professor Univ. ofAdresse e-mail validée de scilifelab.se
Sabiha EssackAntimicrobial Research Unit, University of KwaZulu-NatalAdresse e-mail validée de ukzn.ac.za
Tricia NaickerUniversity of KwaZulu NatalAdresse e-mail validée de ukzn.ac.za
Yasien Sayed, PhDProfessor of Biochemistry, University of the Witwatersrand, JohannesburgAdresse e-mail validée de wits.ac.za
Mahmoud SolimanProfessor, University of Kwazulu-NatalAdresse e-mail validée de ukzn.ac.za
Roger Paredes, MD, PhDDepartment of Infectious Diseases & irsiCaixa AIDS Research Institute, Hospital Germans Trias iAdresse e-mail validée de irsicaixa.es
Bahareh HonarparvarSchool of Pharmacy and Pharmacology, University of KwaZulu-Natal, Private Bag X54001, Durban, 4000, South AfricaAdresse e-mail validée de ukzn.ac.za
Katja PetzoldProfessor @ Uppsala University, Uppsala, SwedenAdresse e-mail validée de imbim.uu.se
Maya MakatiniUniversity of the WitwatersrandAdresse e-mail validée de wits.ac.za
Tulio de OliveiraStellenbosch UniversityAdresse e-mail validée de sun.ac.za

Suivre

Raveen Parboosing

National Health Laboratory Service/University of Witwatersrand

Adresse e-mail validée de wits.ac.za - Page d'accueil

Clinical & Diagnostic Virology Immunology Drug Discovery Nanotechnology Epidemiology


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study N Wolter, W Jassat, S Walaza, R Welch, H Moultrie, M Groome, ... The Lancet 399 (10323), 437-446, 2022	1131	2022
The role of nanotechnology in the treatment of viral infections L Singh, HG Kruger, GEM Maguire, T Govender, R Parboosing Therapeutic advances in infectious disease 4 (4), 105-131, 2017	406	2017
Gestational influenza and bipolar disorder in adult offspring R Parboosing, Y Bao, L Shen, CA Schaefer, AS Brown JAMA psychiatry 70 (7), 677-685, 2013	289	2013
Nanotechnology and the treatment of HIV infection R Parboosing, GEM Maguire, P Govender, HG Kruger Viruses 4 (4), 488-520, 2012	166	2012
Defining immune reconstitution inflammatory syndrome: evaluation of expert opinion versus 2 case definitions in a South African cohort LJ Haddow, PJ Easterbrook, A Mosam, NG Khanyile, R Parboosing, ... Clinical Infectious Diseases 49 (9), 1424-1432, 2009	141	2009
Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa LJ Haddow, MYS Moosa, A Mosam, P Moodley, R Parboosing, ... PloS one 7 (11), e40623, 2012	121	2012
Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta‐analysis J Riou, M Aït Ahmed, A Blake, S Vozlinsky, S Brichler, S Eholié, PY Boëlle, ... Journal of viral hepatitis 23 (4), 244-255, 2016	113	2016
Metal nanoparticles: a promising treatment for viral and arboviral infections K Maduray, R Parboosing Biological Trace Element Research 199 (8), 3159-3176, 2021	105	2021
Clinical severity of SARS-CoV-2 Omicron BA. 4 and BA. 5 lineages compared to BA. 1 and Delta in South Africa N Wolter, W Jassat, S Walaza, R Welch, H Moultrie, MJ Groome, ... Nature communications 13 (1), 5860, 2022	84	2022
NOTA: a potent metallo-β-lactamase inhibitor AM Somboro, D Tiwari, LA Bester, R Parboosing, L Chonco, HG Kruger, ... Journal of Antimicrobial Chemotherapy 70 (5), 1594-1596, 2015	80	2015
Traumatic brain contusions: a clinical role for the kinin antagonist CP-0127 PK Narotam, TC Rodell, SS Nadvi, KD Bhoola, JM Troha, ... Acta neurochirurgica 140, 793-803, 1998	61	1998
Hepatitis C virus seropositivity in a South African Cohort of HIV co‐infected, ARV naïve patients is associated with renal insufficiency and increased mortality R Parboosing, I Paruk, UG Lalloo Journal of medical virology 80 (9), 1530-1536, 2008	53	2008
In vitro evaluation of metal chelators as potential metallo‐ β ‐lactamase inhibitors R Azumah, J Dutta, AM Somboro, M Ramtahal, L Chonco, R Parboosing, ... Journal of Applied Microbiology 120 (4), 860-867, 2016	51	2016
Hepatitis B and HIV co-infection in pregnant women: indication for routine antenatal hepatitis B virus screening in a high HIV prevalence setting NV Thumbiran, D Moodley, R Parboosing, P Moodley South African Medical Journal 104 (4), 307-309, 2014	51	2014
Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors: A hybrid 2D NMR and docking/QM/MM/MD approach MM Makatini, K Petzold, SN Sriharsha, N Ndlovu, MES Soliman, ... European journal of medicinal chemistry 46 (9), 3976-3985, 2011	49	2011
Synthesis, ⁶⁸Ga‐Radiolabeling, and Preliminary In Vivo Assessment of a Depsipeptide‐Derived Compound as a Potential PET/CT Infection Imaging Agent BB Mokaleng, T Ebenhan, S Ramesh, T Govender, HG Kruger, ... BioMed research international 2015 (1), 284354, 2015	45	2015
Clinical severity of omicron lineage BA. 2 infection compared with BA. 1 infection in South Africa N Wolter, W Jassat, A von Gottberg, C Cohen The Lancet 400 (10346), 93-96, 2022	44	2022
In Vitro Antibacterial Activity of Teixobactin Derivatives on Clinically Relevant Bacterial Isolates EJ Ramchuran, AM Somboro, SAH Abdel Monaim, DG Amoako, ... Frontiers in Microbiology 9, 1535, 2018	39	2018
Cell-based assays for assessing toxicity: a basic guide R Parboosing, G Mzobe, L Chonco, I Moodley Medicinal Chemistry 13 (1), 13-21, 2017	33	2017
Cerebellar abscess: the significance of cerebrospinal fluid diversion SS Nadvi, R Parboosing, JR van Dellen Neurosurgery 41 (1), 61-67, 1997	33	1997

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs